Viewing Study NCT07290894


Ignite Creation Date: 2025-12-25 @ 1:27 AM
Ignite Modification Date: 2025-12-25 @ 11:39 PM
Study NCT ID: NCT07290894
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-18
First Post: 2025-11-21
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Pembrolizumab Plus Lenvatinib in Vulvar Cancer Patients: MITO VULVA-01
Sponsor: National Cancer Institute, Naples
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module